Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Yoo, Yoon Seon ^a   Han, Hye Gyeong ^a   Jeon, Young Joo ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; MACHINERY; PHYSIOLOGY; QUALITY CONTROL; TUMORS;

ADAPTIVE CAPACITY; ENDOPLASMIC RETICULUM; EUKARYOTIC CELLS; IMMUNOGENICITY; THERAPEUTIC INTERVENTION; TRANS-MEMBRANE PROTEINS; TUMOR PROGRESSIONS; UNFOLDED PROTEIN RESPONSE;

PROTEINS;

ANTINEOPLASTIC AGENT;

CANCER THERAPY; CARCINOGENESIS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; IMMUNOGENICITY; MALIGNANT NEOPLASM; PROTEIN HOMEOSTASIS; PROTEIN MISFOLDING; REVIEW; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE; DISEASE EXACERBATION; IMMUNOLOGY; NEOPLASM;

AGING; DEGRADATION; PROTEINS; QUALITY CONTROL;

DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; HUMANS; NEOPLASMS; UNFOLDED PROTEIN RESPONSE;

EID: 85042590923     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/2969271     Document Type: Review

References (264)

1. G. Griffiths, G. Warren, P. Quinn, O. Mathieu-Costello, and H. Hoppeler, "Density of newly synthesized plasma membrane proteins in intracellular membranes. I. Stereological studies," Journal of Cell Biology, vol. 98, no. 6, pp. 2133-2141, 1984.
2. O. Baumann and B. Walz, "Endoplasmic reticulum of animal cells and its organization into structural and functional domains," International Review of Cytology, vol. 205, pp. 149-214, 2001.
3. D. T. Rutkowski and R. S. Hegde, "Regulation of basal cellular physiology by the homeostatic unfolded protein response," The Journal of Cell Biology, vol. 189, no. 5, pp. 783-794, 2010.
4. M. J. Berridge, P. Lipp, and M. D. Bootman, "The versatility and universality of calcium signalling," Nature Reviews Molecular Cell Biology, vol. 1, no. 1, pp. 11-21, 2000.
5. S. A. Oakes and F. R. Papa, "The role of endoplasmic reticulum stress in human pathology," Annual Review of Pathology: Mechanisms of Disease, vol. 10, no. 1, pp. 173-194, 2015.
6. M. Wang and R. J. Kaufman, "The impact of the endoplasmic reticulum protein-folding environment on cancer development," Nature Reviews Cancer, vol. 14, no. 9, pp. 581-597, 2014.
7. D. Morito and K. Nagata, "Pathogenic hijacking of ERassociated degradation: is ERAD flexible?," Molecular Cell, vol. 59, no. 3, pp. 335-344, 2015.
8. F. U. Hartl and M. Hayer-Hartl, "Converging concepts of protein folding in vitro and in vivo," Nature Structural &Molecular Biology, vol. 16, no. 6, pp. 574-581, 2009.
9. A. Ruggiano, O. Foresti, and P. Carvalho, "Quality control: ER-associated degradation: protein quality control and beyond," Journal of Cell Biology, vol. 204, no. 6, pp. 869-879, 2014.
10. J. L. Brodsky and R. J. Wojcikiewicz, "Substrate-specific mediators of ER associated degradation (ERAD)," Current Opinion in Cell Biology, vol. 21, no. 4, pp. 516-521, 2009.
11. R. Y. Hampton, "ER-associated degradation in protein quality control and cellular regulation," Current Opinion in Cell Biology, vol. 14, no. 4, pp. 476-482, 2002.
12. S. S. Vembar and J. L. Brodsky, "One step at a time: endoplasmic reticulum-associated degradation," Nature Reviews Molecular Cell Biology, vol. 9, no. 12, pp. 944-957, 2008.
13. A. Hershko and A. Ciechanover, "The ubiquitin system," Annual Review of Biochemistry, vol. 67, no. 1, pp. 425-479, 1998.
14. C. Lopez-Otin, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, "The hallmarks of aging," Cell, vol. 153, no. 6, pp. 1194-1217, 2013.
15. R. C. Taylor and A. Dillin, "Aging as an event of proteostasis collapse," Cold Spring Harbor Perspectives in Biology, vol. 3, no. 5, pp. 1-17, 2011.
16. F. Chiti and C. M. Dobson, "Protein misfolding, functional amyloid, and human disease," Annual Review of Biochemistry, vol. 75, no. 1, pp. 333-366, 2006.
17. M. Wang and R. J. Kaufman, "Protein misfolding in the endoplasmic reticulum as a conduit to human disease," Nature, vol. 529, no. 7586, pp. 326-335, 2016.
18. T. K. Rainbolt, J. M. Saunders, and R. L. Wiseman, "Stressresponsive regulation of mitochondria through the ER unfolded protein response," Trends in Endocrinology &Metabolism, vol. 25, no. 10, pp. 528-537, 2014.
19. N. Hiramatsu, W. C. Chiang, T. D. Kurt, C. J. Sigurdson, and J. H. Lin, "Multiple mechanisms of unfolded protein response-induced cell death," The American Journal of Pathology, vol. 185, no. 7, pp. 1800-1808, 2015.
20. J. H. Otero, B. Lizak, and L. M. Hendershot, "Life and death of a BiP substrate," Seminars in Cell &Developmental Biology, vol. 21, no. 5, pp. 472-478, 2010.
21. A. Bertolotti, Y. Zhang, L. M. Hendershot, H. P. Harding, and D. Ron, "Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response," Nature Cell Biology, vol. 2, no. 6, pp. 326-332, 2000.
22. J. Shen, E. L. Snapp, J. Lippincott-Schwartz, and R. Prywes, "Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response," Molecular and Cellular Biology, vol. 25, no. 3, pp. 921-932, 2005.
23. D. Pincus, M. W. Chevalier, T. Aragon et al., "BiP binding to the ER-stress sensor Ire1 tunes the homeostatic behavior of the unfolded protein response," PLoS Biology, vol. 8, no. 7, article e1000415, 2010.
24. B. M. Gardner and P. Walter, "Unfolded proteins are Ire1-activating ligands that directly induce the unfolded protein response," Science, vol. 333, no. 6051, pp. 1891-1894, 2011.
25. A. V. Korennykh, P. F. Egea, A. A. Korostelev et al., "The unfolded protein response signals through high-order assembly of Ire1," Nature, vol. 457, no. 7230, pp. 687-693, 2008.
26. H. Li, A. V. Korennykh, S. L. Behrman, and P. Walter, "Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 37, pp. 16113-16118, 2010.
27. P. Walter and D. Ron, "The unfolded protein response: from stress pathway to homeostatic regulation," Science, vol. 334, no. 6059, pp. 1081-1086, 2011.
28. D. Ron and P. Walter, "Signal integration in the endoplasmic reticulum unfolded protein response," Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 519-529, 2007.
29. G. V. Di Prisco, W. Huang, S. A. Buffington et al., "Translational control of mGluR-dependent long-term depression and object-place learning by eIF2α," Nature Neuroscience, vol. 17, no. 8, pp. 1073-1082, 2014.
30. J. Han, S. H. Back, J. Hur et al., "ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death," Nature Cell Biology, vol. 15, no. 5, pp. 481-490, 2013.
31. H. P. Harding, Y. Zhang, D. Scheuner, J. J. Chen, R. J. Kaufman, and D. Ron, "Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2α) dephosphorylation in mammalian development," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1832-1837, 2009.
32. D. T. Rutkowski, S. M. Arnold, C. N. Miller et al., "Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins," PLoS Biology, vol. 4, no. 11, article e374, 2006.
33. J. H. Lin, H. Li, D. Yasumura et al., "IRE1 signaling affects cell fate during the unfolded protein response," Science, vol. 318, no. 5852, pp. 944-949, 2007.
34. H. P. Harding, Y. Zhang, and D. Ron, "Protein translation and folding are coupled by an endoplasmic-reticulumresident kinase," Nature, vol. 397, no. 6716, pp. 271-274, 1999.
35. K. M. Vattem and R. C. Wek, "Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 31, pp. 11269-11274, 2004.
36. H. P. Harding, Y. Zhang, H. Zeng et al., "An integrated stress response regulates amino acid metabolism and resistance to oxidative stress," Molecular Cell, vol. 11, no. 3, pp. 619-633, 2003.
37. S. J. Marciniak, C. Y. Yun, S. Oyadomari et al., "CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum," Genes &Development, vol. 18, no. 24, pp. 3066-3077, 2004.
38. B. Song, D. Scheuner, D. Ron, S. Pennathur, and R. J. Kaufman, "Chop deletion reduces oxidative stress, improves β cell function, and promotes cell survival in multiple mouse models of diabetes," The Journal of Clinical Investigation, vol. 118, no. 10, pp. 3378-3389, 2008.
39. N. S. Chitnis, D. Pytel, E. Bobrovnikova-Marjon et al., "miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner," Molecular Cell, vol. 48, no. 3, pp. 353-364, 2012.
40. C. W. Woo, L. Kutzler, S. R. Kimball, and I. Tabas, "Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of eIF2B," Nature Cell Biology, vol. 14, no. 2, pp. 192-200, 2012.
41. W. Tirasophon, A. A. Welihinda, and R. J. Kaufman, "A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/ endoribonuclease (Ire1p) in mammalian cells," Genes &Development, vol. 12, no. 12, pp. 1812-1824, 1998.
42. H. Yoshida, T. Matsui, A. Yamamoto, T. Okada, and K. Mori, "XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor," Cell, vol. 107, no. 7, pp. 881-891, 2001.
43. A. H. Lee, N. N. Iwakoshi, and L. H. Glimcher, "XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response," Molecular and Cellular Biology, vol. 23, no. 21, pp. 7448-7459, 2003.
44. J. R. Hassler, D. L. Scheuner, S. Wang et al., "The IRE1α/ XBP1s pathway is essential for the glucose response and protection of β cells," PLoS Biology, vol. 13, no. 10, article e1002277, 2015.
45. M. Calfon, H. Zeng, F. Urano et al., "IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA," Nature, vol. 415, no. 6867, pp. 92-96, 2002.
46. H. Yoshida, M. Oku, M. Suzuki, and K. Mori, "pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response," Journal of Cell Biology, vol. 172, no. 4, pp. 565-575, 2006.
47. R. Ghosh, L. Wang, E. S. Wang et al., "Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress," Cell, vol. 158, no. 3, pp. 534-548, 2014.
48. A. G. Lerner, J. P. Upton, P. V. Praveen et al., "IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress," Cell Metabolism, vol. 16, no. 2, pp. 250-264, 2012.
49. J. P. Upton, L. Wang, D. Han et al., "IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic caspase-2," Science, vol. 338, no. 6108, pp. 818-822, 2012.
50. K. Haze, H. Yoshida, H. Yanagi, T. Yura, and K. Mori, "Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress," Molecular Biology of the Cell, vol. 10, no. 11, pp. 3787-3799, 1999.
51. K. Lee, W. Tirasophon, X. Shen et al., "IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response," Genes &Development, vol. 16, no. 4, pp. 452-466, 2002.
52. K. Yamamoto, T. Sato, T. Matsui et al., "Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6α and XBP1," Developmental Cell, vol. 13, no. 3, pp. 365-376, 2007.
53. M. D. Shoulders, L. M. Ryno, J. C. Genereux et al., "Stressindependent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments," Cell Reports, vol. 3, no. 4, pp. 1279-1292, 2013.
54. K. E. Matlack, W. Mothes, and T. A. Rapoport, "Protein translocation: tunnel vision," Cell, vol. 92, no. 3, pp. 381-390, 1998.
55. A. Helenius, T. Marquardt, and I. Braakman, "The endoplasmic reticulum as a protein-folding compartment," Trends in Cell Biology, vol. 2, no. 8, pp. 227-231, 1992.
56. A. Helenius, E. S. Trombetta, D. N. Hebert, and J. F. Simons, "Calnexin, calreticulin and the folding of glycoproteins," Trends in Cell Biology, vol. 7, no. 5, pp. 193-200, 1997.
57. L. Ellgaard, M. Molinari, and A. Helenius, "Setting the standards: quality control in the secretory pathway," Science, vol. 286, no. 5446, pp. 1882-1888, 1999.
58. A. Zapun, C. A. Jakob, D. Y. Thomas, and J. J. Bergeron, "Protein folding in a specialized compartment: the endoplasmic reticulum," Structure, vol. 7, no. 8, pp. R173-R182, 1999.
59. C. S. Sevier and C. A. Kaiser, "Formation and transfer of disulphide bonds in living cells," Nature Reviews Molecular Cell Biology, vol. 3, no. 11, pp. 836-847, 2002.
60. B. P. Tu and J. S. Weissman, "Oxidative protein folding in eukaryotes: mechanisms and consequences," Journal of Cell Biology, vol. 164, no. 3, pp. 341-346, 2004.
61. H. Saibil, "Chaperone machines for protein folding, unfolding and disaggregation," Nature Reviews Molecular Cell Biology, vol. 14, no. 10, pp. 630-642, 2013.
62. M. Schroder and R. J. Kaufman, "The mammalian unfolded protein response," Annual Review of Biochemistry, vol. 74, no. 1, pp. 739-789, 2005.
63. J. C. Christianson and Y. Ye, "Cleaning up in the endoplasmic reticulum: ubiquitin in charge," Nature Structural &Molecular Biology, vol. 21, no. 4, pp. 325-335, 2014.
64. J. A. Olzmann, R. R. Kopito, and J. C. Christianson, "The mammalian endoplasmic reticulum-associated degradation system," Cold Spring Harbor Perspectives in Biology, vol. 5, no. 9, pp. 1-16, 2013.
65. C. Xu and D. T. Ng, "Glycosylation-directed quality control of protein folding," Nature Reviews Molecular Cell Biology, vol. 16, no. 12, pp. 742-752, 2015.
66. E. J. Wiertz, T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh, "The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol," Cell, vol. 84, no. 5, pp. 769-779, 1996.
67. K. Fujita, S. Omura, and J. Silver, "Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors," Journal of General Virology, vol. 78, no. 3, pp. 619-625, 1997.
68. U. Schubert, L. C. Anton, I. Bacik et al., "CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway," Journal of Virology, vol. 72, no. 3, pp. 2280-2288, 1998.
69. N. Yagishita, K. Ohneda, T. Amano et al., "Essential role of synoviolin in embryogenesis," Journal of Biological Chemistry, vol. 280, no. 9, pp. 7909-7916, 2005.
70. A. B. Francisco, R. Singh, S. Li et al., "Deficiency of suppressor enhancer Lin12 1 like (SEL1L) in mice leads to systemic endoplasmic reticulum stress and embryonic lethality," Journal of Biological Chemistry, vol. 285, no. 18, pp. 13694-13703, 2010.
71. Y. Eura, H. Yanamoto, Y. Arai, T. Okuda, T. Miyata, and K. Kokame, "Derlin-1 deficiency is embryonic lethal, Derlin-3 deficiency appears normal, and Herp deficiency is intolerant to glucose load and ischemia in mice," PLoS One, vol. 7, no. 3, article e34298, 2012.
72. C. J. Guerriero and J. L. Brodsky, "The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology," Physiological Reviews, vol. 92, no. 2, pp. 537-576, 2012.
73. A. Helenius and M. Aebi, "Roles of N-linked glycans in the endoplasmic reticulum," Annual Review of Biochemistry, vol. 73, no. 1, pp. 1019-1049, 2004.
74. M. Aebi, R. Bernasconi, S. Clerc, and M. Molinari, "N-glycan structures: recognition and processing in the ER," Trends in Biochemical Sciences, vol. 35, no. 2, pp. 74-82, 2010.
75. D. N. Hebert, R. Bernasconi, and M. Molinari, "ERAD substrates: which way out?," Seminars in Cell &Developmental Biology, vol. 21, no. 5, pp. 526-532, 2010.
76. G. Z. Lederkremer, "Glycoprotein folding, quality control and ER-associated degradation," Current Opinion in Structural Biology, vol. 19, no. 5, pp. 515-523, 2009.
77. D. S. Gonzalez, K. Karaveg, A. S. Vandersall-Nairn, A. Lal, and K. W. Moremen, "Identification, expression, and characterization of a cDNA encoding human endoplasmic reticulum mannosidase I, the enzyme that catalyzes the first mannose trimming step in mammalian Asn-linked oligosaccharide biosynthesis," Journal of Biological Chemistry, vol. 274, no. 30, pp. 21375-21386, 1999.
78. L. O. Tremblay and A. Herscovics, "Cloning and expression of a specific human alpha 1,2-mannosidase that trims Man9-GlcNAc2 to Man8GlcNAc2 isomer B during N-glycan biosynthesis," Glycobiology, vol. 9, no. 10, pp. 1073-1078, 1999.
79. S. Olivari, T. Cali, K. E. Salo, P. Paganetti, L. W. Ruddock, and M. Molinari, "EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation," Biochemical and Biophysical Research Communications, vol. 349, no. 4, pp. 1278-1284, 2006.
80. N. Hosokawa, L. O. Tremblay, B. Sleno et al., "EDEM1 accelerates the trimming of alpha1,2-linked mannose on the C branch of N-glycans," Glycobiology, vol. 20, no. 5, pp. 567-575, 2010.
81. K. Hirao, Y. Natsuka, T. Tamura et al., "EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming," Journal of Biological Chemistry, vol. 281, no. 14, pp. 9650-9658, 2006.
82. N. Hosokawa, Y. Kamiya, D. Kamiya, K. Kato, and K. Nagata, "Human OS-9, a lectin required for glycoprotein endoplasmic reticulum-associated degradation, recognizes mannosetrimmed N-glycans," Journal of Biological Chemistry, vol. 284, no. 25, pp. 17061-17068, 2009.
83. N. Hosokawa, Z. You, L. O. Tremblay, K. Nagata, and A. Herscovics, "Stimulation of ERAD of misfolded null Hong Kong α1-antitrypsin by Golgi α1,2-mannosidases," Biochemical and Biophysical Research Communications, vol. 362, no. 3, pp. 626-632, 2007.
84. R. Bernasconi, T. Pertel, J. Luban, and M. Molinari, "A dual task for the Xbp1-responsive OS-9 variants in the mammalian endoplasmic reticulum: inhibiting secretion of misfolded protein conformers and enhancing their disposal," Journal of Biological Chemistry, vol. 283, no. 24, pp. 16446-16454, 2008.
85. J. C. Christianson, T. A. Shaler, R. E. Tyler, and R. R. Kopito, "OS-9 and GRP94 deliver mutant α1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD," Nature Cell Biology, vol. 10, no. 3, pp. 272-282, 2008.
86. N. Hosokawa, I. Wada, K. Nagasawa, T. Moriyama, K. Okawa, and K. Nagata, "Human XTP3-B forms an endoplasmic reticulum quality control scaffold with the HRD1-SEL1L ubiquitin ligase complex and BiP," Journal of Biological Chemistry, vol. 283, no. 30, pp. 20914-20924, 2008.
87. R. Bernasconi, C. Galli, V. Calanca, T. Nakajima, and M. Molinari, "Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates," Journal of Cell Biology, vol. 188, no. 2, pp. 223-235, 2010.
88. R. K. Plemper, S. Bohmler, J. Bordallo, T. Sommer, and D. H. Wolf, "Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation," Nature, vol. 388, no. 6645, pp. 891-895, 1997.
89. R. Ushioda, J. Hoseki, and K. Nagata, "Glycosylation-independent ERAD pathway serves as a backup system under ER stress," Molecular Biology of the Cell, vol. 24, no. 20, pp. 3155-3163, 2013.
90. M. Shenkman, B. Groisman, E. Ron, E. Avezov, L. M. Hendershot, and G. Z. Lederkremer, "A shared endoplasmic reticulum-associated degradation pathway involving the EDEM1 protein for glycosylated and nonglycosylated proteins," Journal of Biological Chemistry, vol. 288, no. 4, pp. 2167-2178, 2013.
91. J. L. Brodsky and W. R. Skach, "Protein folding and quality control in the endoplasmic reticulum: recent lessons from yeast and mammalian cell systems," Current Opinion in Cell Biology, vol. 23, no. 4, pp. 464-475, 2011.
92. S. Grubb, L. Guo, E. A. Fisher, and J. L. Brodsky, "Protein disulfide isomerases contribute differentially to the endoplasmic reticulum-associated degradation of apolipoprotein B and other substrates," Molecular Biology of the Cell, vol. 23, no. 4, pp. 520-532, 2012.
93. R. Y. Hampton and T. Sommer, "Finding the will and the way of ERAD substrate retrotranslocation," Current Opinion in Cell Biology, vol. 24, no. 4, pp. 460-466, 2012.
94. H. Meyer, M. Bug, and S. Bremer, "Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system," Nature Cell Biology, vol. 14, no. 2, pp. 117-123, 2012.
95. T. Huyton, V. E. Pye, L. C. Briggs et al., "The crystal structure of murine p97/VCP at 3.6A," Journal of Structural Biology, vol. 144, no. 3, pp. 337-348, 2003.
96. B. DeLaBarre and A. T. Brunger, "Complete structure of p97/ valosin-containing protein reveals communication between nucleotide domains," Nature Structural Biology, vol. 10, no. 10, pp. 856-863, 2003.
97. I. Dreveny, H. Kondo, K. Uchiyama, A. Shaw, X. Zhang, and P. S. Freemont, "Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47," The EMBO Journal, vol. 23, no. 5, pp. 1030-1039, 2004.
98. H. Meyer and C. C. Weihl, "The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis," Journal of Cell Science, vol. 127, no. 18, pp. 3877-3883, 2014.
99. P. H. Vekaria, T. Home, S. Weir, F. J. Schoenen, and R. Rao, "Targeting p97 to disrupt protein homeostasis in cancer," Frontiers in Oncology, vol. 6, p. 181, 2016.
100. M. Mehnert, T. Sommer, and E. Jarosch, "Der1 promotes movement of misfolded proteins through the endoplasmic reticulum membrane," Nature Cell Biology, vol. 16, no. 1, pp. 77-86, 2014.
101. J. Wahlman, G. N. DeMartino, W. R. Skach, N. J. Bulleid, J. L. Brodsky, and A. E. Johnson, "Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system," Cell, vol. 129, no. 5, pp. 943-955, 2007.
102. E. J. Greenblatt, J. A. Olzmann, and R. R. Kopito, "Derlin-1 is a rhomboid pseudoprotease required for the dislocation of mutant α-1 antitrypsin from the endoplasmic reticulum," Nature Structural &Molecular Biology, vol. 18, no. 10, pp. 1147-1152, 2011.
103. B. N. Lilley and H. L. Ploegh, "A membrane protein required for dislocation of misfolded proteins from the ER," Nature, vol. 429, no. 6994, pp. 834-840, 2004.
104. Y. Ye, Y. Shibata, C. Yun, D. Ron, and T. A. Rapoport, "A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol," Nature, vol. 429, no. 6994, pp. 841-847, 2004.
105. Y. Ye, Y. Shibata, M. Kikkert, S. van Voorden, E. Wiertz, and T. A. Rapoport, "Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 40, pp. 14132-14138, 2005.
106. Y. Oda, T. Okada, H. Yoshida, R. J. Kaufman, K. Nagata, and K. Mori, "Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ERassociated degradation," Journal of Cell Biology, vol. 172, no. 3, pp. 383-393, 2006.
107. B. N. Lilley and H. L. Ploegh, "Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 40, pp. 14296-14301, 2005.
108. L. Fleig, N. Bergbold, P. Sahasrabudhe, B. Geiger, L. Kaltak, and M. K. Lemberg, "Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins," Molecular Cell, vol. 47, no. 4, pp. 558-569, 2012.
109. J. L. Brodsky, "Cleaning up: ER-associated degradation to the rescue," Cell, vol. 151, no. 6, pp. 1163-1167, 2012.
110. J. M. Williams, T. Inoue, L. Banks, and B. Tsai, "The ERdj5-Sel1L complex facilitates cholera toxin retrotranslocation," Molecular Biology of the Cell, vol. 24, no. 6, pp. 785-795, 2013.
111. B. Mueller, B. N. Lilley, and H. L. Ploegh, "SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER," Journal of Cell Biology, vol. 175, no. 2, pp. 261-270, 2006.
112. B. Mueller, E. J. Klemm, E. Spooner, J. H. Claessen, and H. L. Ploegh, "SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 34, pp. 12325-12330, 2008.
113. Y. Iida, T. Fujimori, K. Okawa, K. Nagata, I. Wada, and N. Hosokawa, "SEL1L protein critically determines the stability of the HRD1-SEL1L endoplasmic reticulum-associated degradation (ERAD) complex to optimize the degradation kinetics of ERAD substrates," Journal of Biological Chemistry, vol. 286, no. 19, pp. 16929-16939, 2011.
114. E. J. Klemm, E. Spooner, and H. L. Ploegh, "Dual role of ancient ubiquitous protein 1 (AUP1) in lipid droplet accumulation and endoplasmic reticulum (ER) protein quality control," Journal of Biological Chemistry, vol. 286, no. 43, pp. 37602-37614, 2011.
115. J. C. Christianson, J. A. Olzmann, T. A. Shaler et al., "Defining human ERAD networks through an integrative mapping strategy," Nature Cell Biology, vol. 14, no. 1, pp. 93-105, 2011.
116. R. G. Gardner, G. M. Swarbrick, N. W. Bays et al., "Endoplasmic reticulum degradation requires lumen to cytosol signaling. Transmembrane control of Hrd1p by Hrd3p," The Journal of Cell Biology, vol. 151, no. 1, pp. 69-82, 2000.
117. P. Carvalho, V. Goder, and T. A. Rapoport, "Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins," Cell, vol. 126, no. 2, pp. 361-373, 2006.
118. V. Denic, E. M. Quan, and J. S. Weissman, "A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation," Cell, vol. 126, no. 2, pp. 349-359, 2006.
119. R. Gauss, E. Jarosch, T. Sommer, and C. Hirsch, "A complex of Yos9p and the HRD ligase integrates endoplasmic reticulum quality control into the degradation machinery," Nature Cell Biology, vol. 8, no. 8, pp. 849-854, 2006.
120. S. Sun, G. Shi, X. Han et al., "Sel1L is indispensable for mammalian endoplasmic reticulum-associated degradation, endoplasmic reticulum homeostasis, and survival," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 5, pp. E582-E591, 2014.
121. J. P. Lu, Y. Wang, D. A. Sliter, M. M. Pearce, and R. J. Wojcikiewicz, "RNF170 protein, an endoplasmic reticulum membrane ubiquitin ligase, mediates inositol 1,4,5-trisphosphate receptor ubiquitination and degradation," The Journal of Biological Chemistry, vol. 286, no. 27, pp. 24426-24433, 2011.
122. Y. J. Jeon, J. H. Park, and C. H. Chung, "Interferon-stimulated gene 15 in the control of cellular responses to genotoxic stress," Molecules and Cells, vol. 40, no. 2, pp. 83-89, 2017.
123. K. D. Wilkinson, "Regulation of ubiquitin-dependent processes by deubiquitinating enzymes," The FASEB Journal, vol. 11, no. 14, pp. 1245-1256, 1997.
124. Y. Shimizu, Y. Okuda-Shimizu, and L. M. Hendershot, "Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids," Molecular Cell, vol. 40, no. 6, pp. 917-926, 2010.
125. X. Wang, R. A. Herr, W. J. Chua, L. Lybarger, E. J. Wiertz, and T. H. Hansen, "Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3," The Journal of Cell Biology, vol. 177, no. 4, pp. 613-624, 2007.
126. S. Ishikura, A. M. Weissman, and J. S. Bonifacino, "Serine residues in the cytosolic tail of the T-cell antigen receptor alpha-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein," The Journal of Biological Chemistry, vol. 285, no. 31, pp. 23916-23924, 2010.
127. F. Ikeda and I. Dikic, "Atypical ubiquitin chains: new molecular signals. 'Protein modifications: beyond the usual Suspects' review series," EMBO Reports, vol. 9, no. 6, pp. 536-542, 2008.
128. Y. Kulathu and D. Komander, "Atypical ubiquitylation\-The unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages," Nature Reviews. Molecular Cell Biology, vol. 13, no. 8, pp. 508-523, 2012.
129. C. M. Pickart and D. Fushman, "Polyubiquitin chains: polymeric protein signals," Current Opinion in Chemical Biology, vol. 8, no. 6, pp. 610-616, 2004.
130. W. Li and Y. Ye, "Polyubiquitin chains: functions, structures, and mechanisms," Cellular and Molecular Life Sciences, vol. 65, no. 15, pp. 2397-2406, 2008.
131. E. Nadav, A. Shmueli, H. Barr, H. Gonen, A. Ciechanover, and Y. Reiss, "A novel mammalian endoplasmic reticulum ubiquitin ligase homologous to the yeast Hrd1," Biochemical and Biophysical Research Communications, vol. 303, no. 1, pp. 91-97, 2003.
132. M. Kikkert, R. Doolman, M. Dai et al., "Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum," The Journal of Biological Chemistry, vol. 279, no. 5, pp. 3525-3534, 2004.
133. S. Fang, M. Ferrone, C. Yang, J. P. Jensen, S. Tiwari, and A. M. Weissman, "The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 25, pp. 14422-14427, 2001.
134. G. Hassink, M. Kikkert, S. van Voorden et al., "TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum," Biochemical Journal, vol. 388, no. 2, pp. 647-655, 2005.
135. J. M. Younger, L. Chen, H. Y. Ren et al., "Sequential qualitycontrol checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator," Cell, vol. 126, no. 3, pp. 571-582, 2006.
136. D. Morito, K. Hirao, Y. Oda et al., "Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508," Molecular Biology of the Cell, vol. 19, no. 4, pp. 1328-1336, 2008.
137. Y. J. Jeon, S. Khelifa, B. Ratnikov et al., "Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies," Cancer Cell, vol. 27, no. 3, pp. 354-369, 2015.
138. V. Tomati, E. Sondo, A. Armirotti et al., "Genetic inhibition of the ubiquitin ligase Rnf5 attenuates phenotypes associated to F508del cystic fibrosis mutation," Scientific Reports, vol. 5, no. 1, p. 12138, 2015.
139. Y. Imai, M. Soda, S. Hatakeyama et al., "CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity," Molecular Cell, vol. 10, no. 1, pp. 55-67, 2002.
140. G. C. Meacham, C. Patterson, W. Zhang, J. M. Younger, and D. M. Cyr, "The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation," Nature Cell Biology, vol. 3, no. 1, pp. 100-105, 2001.
141. Y. Yoshida, T. Chiba, F. Tokunaga et al., "E3 ubiquitin ligase that recognizes sugar chains," Nature, vol. 418, no. 6896, pp. 438-442, 2002.
142. Y. Yoshida, F. Tokunaga, T. Chiba, K. Iwai, K. Tanaka, and T. Tai, "Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains," The Journal of Biological Chemistry, vol. 278, no. 44, pp. 43877-43884, 2003.
143. J. G. Magadan, F. J. Perez-Victoria, R. Sougrat, Y. Ye, K. Strebel, and J. S. Bonifacino, "Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps," PLoS Pathogens, vol. 6, no. 4, article e1000869, 2010.
144. X. Guo, S. Shen, S. Song et al., "The E3 ligase Smurf1 regulates Wolfram syndrome protein stability at the endoplasmic reticulum," The Journal of Biological Chemistry, vol. 286, no. 20, pp. 18037-18047, 2011.
145. W. H. Fry, C. Simion, C. Sweeney, and K. L. Carraway III, "Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum," Molecular and Cellular Biology, vol. 31, no. 14, pp. 3009-3018, 2011.
146. Y. Jo, P. C. Lee, P. V. Sguigna, and R. A. DeBose-Boyd, "Sterol-induced degradation ofHMGCoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 51, pp. 20503-20508, 2011.
147. T. Zhang, Y. Xu, Y. Liu, and Y. Ye, "gp78 functions downstream of Hrd1 to promote degradation of misfolded proteins of the endoplasmic reticulum," Molecular Biology of the Cell, vol. 26, no. 24, pp. 4438-4450, 2015.
148. A. Stein, A. Ruggiano, P. Carvalho, and T. A. Rapoport, "Key steps in ERAD of luminal ER proteins reconstituted with purified components," Cell, vol. 158, no. 6, pp. 1375-1388, 2014.
149. J. Stevenson, E. Y. Huang, and J. A. Olzmann, "Endoplasmic reticulum-associated degradation and lipid homeostasis," Annual Review of Nutrition, vol. 36, no. 1, pp. 511-542, 2016.
150. A. Shmueli, Y. C. Tsai, M. Yang, M. A. Braun, and A. M. Weissman, "Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum," Biochemical and Biophysical Research Communications, vol. 390, no. 3, pp. 758-762, 2009.
151. P. Ballar, A. U. Ors, H. Yang, and S. Fang, "Differential regulation of CFTRDeltaF508 degradation by ubiquitin ligases gp78 and Hrd1," The International Journal of Biochemistry &Cell Biology, vol. 42, no. 1, pp. 167-173, 2010.
152. M. Knop, A. Finger, T. Braun, K. Hellmuth, and D. H. Wolf, "Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast," The EMBO Journal, vol. 15, no. 4, pp. 753-763, 1996.
153. M. Kothe, Y. Ye, J. S. Wagner et al., "Role of p97 AAAATPase in the retrotranslocation of the cholera toxin A1 chain, a non-ubiquitinated substrate," The Journal of Biological Chemistry, vol. 280, no. 30, pp. 28127-28132, 2005.
154. R. Gauss, T. Sommer, and E. Jarosch, "The Hrd1p ligase complex forms a linchpin between ER-lumenal substrate selection and Cdc48p recruitment," The EMBO Journal, vol. 25, no. 9, pp. 1827-1835, 2006.
155. P. Carvalho, A. M. Stanley, and T. A. Rapoport, "Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-ligase Hrd1p," Cell, vol. 143, no. 4, pp. 579-591, 2010.
156. E. Rabinovich, A. Kerem, K. U. Frohlich, N. Diamant, and S. Bar-Nun, "AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation," Molecular and Cellular Biology, vol. 22, no. 2, pp. 626-634, 2002.
157. Y. Ye, H. H. Meyer, and T. A. Rapoport, "The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol," Nature, vol. 414, no. 6864, pp. 652-656, 2001.
158. J. Liang, C. Yin, H. Doong et al., "Characterization of erasin (UBXD2): a new ER protein that promotes ER-associated protein degradation," Journal of Cell Science, vol. 119, no. 19, pp. 4011-4024, 2006.
159. M. Suzuki, T. Otsuka, Y. Ohsaki et al., "Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets," Molecular Biology of the Cell, vol. 23, no. 5, pp. 800-810, 2012.
160. P. Ballar, Y. Shen, H. Yang, and S. Fang, "The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation," The Journal of Biological Chemistry, vol. 281, no. 46, pp. 35359-35368, 2006.
161. I. Kim, J. Ahn, C. Liu et al., "The Png1-Rad23 complex regulates glycoprotein turnover," The Journal of Cell Biology, vol. 172, no. 2, pp. 211-219, 2006.
162. G. Li, G. Zhao, X. Zhou, H. Schindelin, and W. J. Lennarz, "The AAA ATPase p97 links peptide N-glycanase to the endoplasmic reticulum-associated E3 ligase autocrine motility factor receptor," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 22, pp. 8348-8353, 2006.
163. R. Ernst, B. Mueller, H. L. Ploegh, and C. Schlieker, "The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER," Molecular Cell, vol. 36, no. 1, pp. 28-38, 2009.
164. M. E. Sowa, E. J. Bennett, S. P. Gygi, and J. W. Harper, "Defining the human deubiquitinating enzyme interaction landscape," Cell, vol. 138, no. 2, pp. 389-403, 2009.
165. Q. Wang, L. Li, and Y. Ye, "Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3," The Journal of Cell Biology, vol. 174, no. 7, pp. 963-971, 2006.
166. Y. Xu, Y. Liu, J. G. Lee, and Y. Ye, "A ubiquitin-like domain recruits an oligomeric chaperone to a retrotranslocation complex in endoplasmic reticulum-associated degradation," The Journal of Biological Chemistry, vol. 288, no. 25, pp. 18068-18076, 2013.
167. Q. Wang, Y. Liu, N. Soetandyo, K. Baek, R. Hegde, and Y. Ye, "A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation," Molecular Cell, vol. 42, no. 6, pp. 758-770, 2011.
168. Y. Xu, M. Cai, Y. Yang, L. Huang, and Y. Ye, "SGTA recognizes a noncanonical ubiquitin-like domain in the Bag6-Ubl4A-Trc35 complex to promote endoplasmic reticulum-associated degradation," Cell Reports, vol. 2, no. 6, pp. 1633-1644, 2012.
169. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation," Cell, vol. 144, no. 5, pp. 646-674, 2011.
170. Y. Ma and L. M. Hendershot, "The role of the unfolded protein response in tumour development: friend or foe?," Nature Reviews. Cancer, vol. 4, no. 12, pp. 966-977, 2004.
171. D. Ruggero, "Translational control in cancer etiology," Cold Spring Harbor Perspectives in Biology, vol. 5, no. 2, pp. 1-27, 2013.
172. H. Urra, E. Dufey, T. Avril, E. Chevet, and C. Hetz, "Endoplasmic reticulum stress and the hallmarks of cancer," Trends in Cancer, vol. 2, no. 5, pp. 252-262, 2016.
173. H. Vanacker, J. Vetters, L. Moudombi, C. Caux, S. Janssens, and M. C. Michallet, "Emerging role of the unfolded protein response in tumor immunosurveillance," Trends in Cancer, vol. 3, no. 7, pp. 491-505, 2017.
174. C. Denoyelle, G. Abou-Rjaily, V. Bezrookove et al., "Antioncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway," Nature Cell Biology, vol. 8, no. 10, pp. 1053-1063, 2006.
175. A. L. Huber, J. Lebeau, P. Guillaumot et al., "p58IPK-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose," Molecular Cell, vol. 49, no. 6, pp. 1049-1059, 2013.
176. G. Ramadori, G. Konstantinidou, N. Venkateswaran et al., "Diet-induced unresolved ER stress hinders KRAS-driven lung tumorigenesis," Cell Metabolism, vol. 21, no. 1, pp. 117-125, 2015.
177. L. Niederreiter, T. M. Fritz, T. E. Adolph et al., "ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells," The Journal of Experimental Medicine, vol. 210, no. 10, pp. 2041-2056, 2013.
178. M. Bi, C. Naczki, M. Koritzinsky et al., "ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth," The EMBO Journal, vol. 24, no. 19, pp. 3470-3481, 2005.
179. J. D. Blais, C. L. Addison, R. Edge et al., "Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress," Molecular and Cellular Biology, vol. 26, no. 24, pp. 9517-9532, 2006.
180. S. Dey, C. M. Sayers, I. I. Verginadis et al., "ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis," The Journal of Clinical Investigation, vol. 125, no. 7, pp. 2592-2608, 2015.
181. S. B. Cullinan, D. Zhang, M. Hannink, E. Arvisais, R. J. Kaufman, and J. A. Diehl, "Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival," Molecular and Cellular Biology, vol. 23, no. 20, pp. 7198-7209, 2003.
182. C. A. Del Vecchio, Y. Feng, E. S. Sokol et al., "De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling," PLoS Biology, vol. 12, no. 9, article e1001945, 2014.
183. W. Zhang, V. Hietakangas, S. Wee, S. C. Lim, J. Gunaratne, and S. M. Cohen, "ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation," Genes &Development, vol. 27, no. 4, pp. 441-449, 2013.
184. D. Pytel, I. Majsterek, and J. A. Diehl, "Tumor progression and the different faces of the PERK kinase," Oncogene, vol. 35, no. 10, pp. 1207-1215, 2016.
185. Y. Kouroku, E. Fujita, I. Tanida et al., "ER stress (PERK/eIF2α phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation," Cell Death and Differentiation, vol. 14, no. 2, pp. 230-239, 2007.
186. W. B'Chir, A. C. Maurin, V. Carraro et al., "The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression," Nucleic Acids Research, vol. 41, no. 16, pp. 7683-7699, 2013.
187. S. I. Grivennikov and M. Karin, "Dangerous liaisons: STAT3 and NF-kB collaboration and crosstalk in cancer," Cytokine &Growth Factor Reviews, vol. 21, no. 1, pp. 11-19, 2010.
188. O. Pluquet, N. Dejeans, M. Bouchecareilh et al., "Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα," Cancer Research, vol. 73, no. 15, pp. 4732-4743, 2013.
189. B. Kharabi Masouleh, H. Geng, C. Hurtz et al., "Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 21, pp. E2219-E2228, 2014.
190. N. Mimura, M. Fulciniti, G. Gorgun et al., "Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma," Blood, vol. 119, no. 24, pp. 5772-5781, 2012.
191. I. Papandreou, N. C. Denko, M. Olson et al., "Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma," Blood, vol. 117, no. 4, pp. 1311-1314, 2011.
192. M. Ri, E. Tashiro, D. Oikawa et al., "Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing," Blood Cancer Journal, vol. 2, no. 7, article e79, 2012.
193. C. Greenman, P. Stephens, R. Smith et al., "Patterns of somatic mutation in human cancer genomes," Nature, vol. 446, no. 7132, pp. 153-158, 2007.
194. Z. Xue, Y. He, K. Ye, Z. Gu, Y. Mao, and L. Qi, "A conserved structural determinant located at the interdomain region of mammalian inositol-requiring enzyme 1α," The Journal of Biological Chemistry, vol. 286, no. 35, pp. 30859-30866, 2011.
195. D. M. Schewe and J. A. Aguirre-Ghiso, "ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10519-10524, 2008.
196. Y. Wang, G. N. Alam, Y. Ning et al., "The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway," Cancer Research, vol. 72, no. 20, pp. 5396-5406, 2012.
197. X. Chen, D. Iliopoulos, Q. Zhang et al., "XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway," Nature, vol. 508, no. 7494, pp. 103-107, 2014.
198. E. Karali, S. Bellou, D. Stellas et al., "VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress," Molecular Cell, vol. 54, no. 4, pp. 559-572, 2014.
199. J. R. Cubillos-Ruiz, S. E. Bettigole, and L. H. Glimcher, "Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer," Cell, vol. 168, no. 4, pp. 692-706, 2017.
200. D. Senft and Z. A. Ronai, "Adaptive stress responses during tumor metastasis and dormancy," Trends in Cancer, vol. 2, no. 8, pp. 429-442, 2016.
201. M. A. Nieto, R. Y. Huang, R. A. Jackson, and J. P. Thiery, "EMT: 2016," Cell, vol. 166, no. 1, pp. 21-45, 2016.
202. H. Mujcic, A. Nagelkerke, K. M. Rouschop et al., "Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3," Clinical Cancer Research, vol. 19, no. 22, pp. 6126-6137, 2013.
203. A. Nagelkerke, J. Bussink, H. Mujcic et al., "Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/ LAMP3-arm of the unfolded protein response," Breast Cancer Res, vol. 15, no. 1, article R2, pp. 467-480, 2013.
204. H. Zhu, X. Chen, B. Chen et al., "Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients," PLoS One, vol. 9, no. 7, article e103882, 2014.
205. G. Auf, A. Jabouille, S. Guerit et al., "Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 35, pp. 15553-15558, 2010.
206. N. Dejeans, O. Pluquet, S. Lhomond et al., "Autocrine control of glioma cells adhesion and migration through IRE1α-mediated cleavage of SPARC mRNA," Journal of Cell Science, vol. 125, Part 18, pp. 4278-4287, 2012.
207. N. R. Mahadevan, J. Rodvold, H. Sepulveda, S. Rossi, A. F. Drew, and M. Zanetti, "Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 16, pp. 6561-6566, 2011.
208. N. R. Mahadevan, V. Anufreichik, J. J. Rodvold, K. T. Chiu, H. Sepulveda, and M. Zanetti, "Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8+ T cell priming," PLoS One, vol. 7, no. 12, article e51845, 2012.
209. J. Pol, E. Vacchelli, F. Aranda et al., "Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy," Oncoimmunology, vol. 4, no. 4, article e1008866, 2015.
210. D. V. Krysko, A. D. Garg, A. Kaczmarek, O. Krysko, P. Agostinis, and P. Vandenabeele, "Immunogenic cell death and DAMPs in cancer therapy," Nature Reviews. Cancer, vol. 12, no. 12, pp. 860-875, 2012.
211. A. R. van Vliet, S. Martin, A. D. Garg, and P. Agostinis, "The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: from sensor to the plasma membrane and beyond," Seminars in Cancer Biology, vol. 33, pp. 74-85, 2015.
212. J. Fucikova, E. Becht, K. Iribarren et al., "Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis," Cancer Research, vol. 76, no. 7, pp. 1746-1756, 2016.
213. A. D. Garg, D. V. Krysko, T. Verfaillie et al., "A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death," The EMBO Journal, vol. 31, no. 5, pp. 1062-1079, 2012.
214. O. Kepp, L. Menger, E. Vacchelli et al., "Crosstalk between ER stress and immunogenic cell death," Cytokine &Growth Factor Reviews, vol. 24, no. 4, pp. 311-318, 2013.
215. C. Pozzi, A. Cuomo, I. Spadoni et al., "The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death," Nature Medicine, vol. 22, no. 6, pp. 624-631, 2016.
216. S. E. Bettigole and L. H. Glimcher, "Endoplasmic reticulum stress in immunity," Annual Review of Immunology, vol. 33, no. 1, pp. 107-138, 2015.
217. N. N. Iwakoshi, A. H. Lee, P. Vallabhajosyula, K. L. Otipoby, K. Rajewsky, and L. H. Glimcher, "Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1," Nature Immunology, vol. 4, no. 4, pp. 321-329, 2003.
218. A. M. Reimold, N. N. Iwakoshi, J. Manis et al., "Plasma cell differentiation requires the transcription factor XBP-1," Nature, vol. 412, no. 6844, pp. 300-307, 2001.
219. R. Hu, Z. F. Chen, J. Yan et al., "Endoplasmic reticulum stress of neutrophils is required for ischemia/reperfusion-induced acute lung injury," Journal of Immunology, vol. 195, no. 10, pp. 4802-4809, 2015.
220. F. Martinon, X. Chen, A. H. Lee, and L. H. Glimcher, "TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages," Nature Immunology, vol. 11, no. 5, pp. 411-418, 2010.
221. J. R. Cubillos-Ruiz, P. C. Silberman, M. R. Rutkowski et al., "ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis," Cell, vol. 161, no. 7, pp. 1527-1538, 2015.
222. A. C. Herrera, V. J. Victorino, F. C. Campos et al., "Impact of tumor removal on the systemic oxidative profile of patients with breast cancer discloses lipid peroxidation at diagnosis as a putative marker of disease recurrence," Clinical Breast Cancer, vol. 14, no. 6, pp. 451-459, 2014.
223. D. L. Herber, W. Cao, Y. Nefedova et al., "Lipid accumulation and dendritic cell dysfunction in cancer," Nature Medicine, vol. 16, no. 8, pp. 880-886, 2010.
224. F. Hossain, A. A. Al-Khami, D. Wyczechowska et al., "Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies," Cancer Immunology Research, vol. 3, no. 11, pp. 1236-1247, 2015.
225. R. Ramakrishnan, V. A. Tyurin, F. Veglia et al., "Oxidized lipids block antigen cross-presentation by dendritic cells in cancer," Journal of Immunology, vol. 192, no. 6, pp. 2920-2931, 2014.
226. D. Yan, H. W. Wang, R. L. Bowman, and J. A. Joyce, "STAT3 and STAT6 signaling pathways synergize to promote Cathepsin secretion from macrophages via IRE1α activation," Cell Reports, vol. 16, no. 11, pp. 2914-2927, 2016.
227. T. Condamine, G. A. Dominguez, J. I. Youn et al., "Lectintype oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients," Science Immunology, vol. 1, no. 2, pp. 1-15, 2016.
228. C. H. Tang, S. Ranatunga, C. L. Kriss et al., "Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival," The Journal of Clinical Investigation, vol. 124, no. 6, pp. 2585-2598, 2014.
229. P. T. Thevenot, R. A. Sierra, P. L. Raber et al., "The stressresponse sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors," Immunity, vol. 41, no. 3, pp. 389-401, 2014.
230. T. Condamine, V. Kumar, I. R. Ramachandran et al., "ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis," The Journal of Clinical Investigation, vol. 124, no. 6, pp. 2626-2639, 2014.
231. X. H. Ma, S. F. Piao, S. Dey et al., "Targeting ER stressinduced autophagy overcomes BRAF inhibitor resistance in melanoma," The Journal of Clinical Investigation, vol. 124, no. 3, pp. 1406-1417, 2014.
232. G. B. Park, D. Y. Hur, and D. Kim, "Combining CAL-101 with celecoxib enhances apoptosis of EBV-transformed B-cells through MAPK-induced ER stress," Anticancer Research, vol. 35, no. 5, pp. 2699-2708, 2015.
233. A. Strasser and H. Puthalakath, "Fold up or perish: unfolded protein response and chemotherapy," Cell Death and Differentiation, vol. 15, no. 2, pp. 223-225, 2007.
234. B. Kharabi Masouleh, E. Chevet, J. Panse et al., "Drugging the unfolded protein response in acute leukemias," Journal of Hematology &Oncology, vol. 8, no. 1, p. 87, 2015.
235. L. Vincenz, R. Jager, M. O'Dwyer, and A. Samali, "Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma," Molecular Cancer Therapeutics, vol. 12, no. 6, pp. 831-843, 2013.
236. K. M. Rouschop, L. J. Dubois, T. G. Keulers et al., "PERK/ eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 12, pp. 4622-4627, 2013.
237. M. Ogata, S. Hino, A. Saito et al., "Autophagy is activated for cell survival after endoplasmic reticulum stress," Molecular and Cellular Biology, vol. 26, no. 24, pp. 9220-9231, 2006.
238. Y. H. Shi, Z. B. Ding, J. Zhou et al., "Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis," Autophagy, vol. 7, no. 10, pp. 1159-1172, 2011.
239. J. R. Cubillos-Ruiz, S. Fiering, and J. R. Conejo-Garcia, "Nanomolecular targeting of dendritic cells for ovarian cancer therapy," Future Oncology, vol. 5, no. 8, pp. 1189-1192, 2009.
240. J. R. Cubillos-Ruiz, J. R. Baird, A. J. Tesone et al., "Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer," Cancer Research, vol. 72, no. 7, pp. 1683-1693, 2012.
241. T. Tanaka, T. Kajiwara, T. Torigoe, Y. Okamoto, N. Sato, and Y. Tamura, "Cancer-associated oxidoreductase ERO1-α drives the production of tumor-promoting myeloid-derived suppressor cells via oxidative protein folding," Journal of Immunology, vol. 194, no. 4, pp. 2004-2010, 2015.
242. I. Saez and D. Vilchez, "The mechanistic links between proteasome activity, aging and age-related diseases," Current Genomics, vol. 15, no. 1, pp. 38-51, 2014.
243. D. Vilchez, I. Saez, and A. Dillin, "The role of protein clearance mechanisms in organismal ageing and age-related diseases," Nature Communications, vol. 5, p. 5659, 2014.
244. M. Cattaneo, E. Fontanella, C. Canton, D. Delia, and I. Biunno, "SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactions," Neoplasia, vol. 7, no. 11, pp. 1030-1038, 2005.
245. H. Kim, A. Bhattacharya, and L. Qi, "Endoplasmic reticulum quality control in cancer: friend or foe," Seminars in Cancer Biology, vol. 33, pp. 25-33, 2015.
246. R. Orlandi, M. Cattaneo, F. Troglio et al., "SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro," Cancer Research, vol. 62, no. 2, pp. 567-574, 2002.
247. H. Ashktorab, W. Green, G. Finzi et al., "SEL1L, an UPR response protein, a potential marker of colonic cell transformation," Digestive Diseases and Sciences, vol. 57, no. 4, pp. 905-912, 2012.
248. J. H. Baek, P. C. Mahon, J. Oh et al., "OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α," Molecular Cell, vol. 17, no. 4, pp. 503-512, 2005.
249. M. Ivan, K. Kondo, H. Yang et al., "HIFα targeted for VHLmediated destruction by proline hydroxylation: implications for O2 sensing," Science, vol. 292, no. 5516, pp. 464-468, 2001.
250. K. Yanagisawa, H. Konishi, C. Arima et al., "Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways," Cancer Research, vol. 70, no. 23, pp. 9949-9958, 2010
251. L. A. Liotta, R. Mandler, G. Murano et al., "Tumor cell autocrine motility factor," Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 10, pp. 3302-3306, 1986.
252. I. R. Nabi and A. Raz, "Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen," International Journal of Cancer, vol. 40, no. 3, pp. 396-402, 1987.
253. V. Joshi, A. Upadhyay, A. Kumar, and A. Mishra, "Gp78 E3 ubiquitin ligase: essential functions and contributions in proteostasis," Frontiers in Cellular Neuroscience, vol. 11, p. 259, 2017.
254. S. Silletti, J. Yao, J. Sanford et al., "Autocrine motility factorreceptor in human bladder-carcinoma-gene-expression, loss of cell-contact regulation and chromosomal mapping," International Journal of Oncology, vol. 3, no. 5, pp. 801-807, 1993.
255. S. Nakamori, H. Watanabe, M. Kameyama et al., "Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence," Cancer, vol. 74, no. 7, pp. 1855-1862, 1994.
256. K. Maruyama, H. Watanabe, H. Shiozaki et al., "Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma," International Journal of Cancer, vol. 64, no. 5, pp. 316-321, 1995.
257. S. Silletti, J. P. Yao, K. J. Pienta, and A. Raz, "Loss of cellcontact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells," International Journal of Cancer, vol. 63, no. 1, pp. 100-105, 1995.
258. T. Otto, W. Birchmeier, U. Schmidt et al., "Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas," Cancer Research, vol. 54, no. 12, pp. 3120-3123, 1994.
259. T. Otto, A. Bex, U. Schmidt, A. Raz, and H. Rubben, "Improved prognosis assessment for patients with bladder carcinoma," The American Journal of Pathology, vol. 150, no. 6, pp. 1919-1923, 1997.
260. K. Kawanishi, Y. Doki, H. Shiozaki et al., "Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers," American Journal of Clinical Pathology, vol. 113, no. 2, pp. 266-274, 2000.
261. Y. C. Tsai, A. Mendoza, J. M. Mariano et al., "The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation," Nature Medicine, vol. 13, no. 12, pp. 1504-1509, 2007.
262. B. Joshi, L. Li, and I. R. Nabi, "A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase," The Journal of Biological Chemistry, vol. 285, no. 12, pp. 8830-8839, 2010.
263. L. Wang, G. Hou, L. Xue, J. Li, P. Wei, and P. Xu, "Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cells," Cancer Investigation, vol. 28, no. 10, pp. 993-1003, 2010.
264. M. Kajiro, R. Hirota, Y. Nakajima et al., "The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways," Nature Cell Biology, vol. 11, no. 3, pp. 312-319, 2009.